According to Aldeyra Therapeutics 's latest financial reports the company's total assets are $0.14 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.14 B | -18.18% |
2022-12-31 | $0.18 B | -22.24% |
2021-12-31 | $0.23 B | 179.7% |
2020-12-31 | $83.35 M | 10.37% |
2019-12-31 | $75.51 M | -20.58% |
2018-12-31 | $95.09 M | 115.26% |
2017-12-31 | $44.17 M | 75.38% |
2016-12-31 | $25.18 M | -10.7% |
2015-12-31 | $28.2 M | 220.98% |
2014-12-31 | $8.78 M | 134.75% |
2013-12-31 | $3.74 M | 89.34% |
2012-12-31 | $1.97 M | 663.61% |
2011-12-31 | $0.25 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Regeneron Pharmaceuticals REGN | $33.08 B | 22,202.21% | ๐บ๐ธ USA |